# Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

> **NCT01296503** · PHASE3 · COMPLETED · sponsor: **Grupo de Estudos Multicentricos em Onco-Hematologia** · enrollment: 213 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide plus dexamethasone
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01296503
- **Lead sponsor:** Grupo de Estudos Multicentricos em Onco-Hematologia
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2008-07
- **Final completion:** 2010-12
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2011-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296503, "Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01296503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*